search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


29 resulaten gevonden voor Amgen in trials

STIP study
- TRIAL ID
NTR6787
- ACRONYMSTIP
Blinatumomab in infant ALL
- TRIAL ID
NTR6359
- ACRONYMBlinatumomab in infant ALL
MBL(Mannose binding lectine)-studie.
- TRIAL ID
NTR3398
- ACRONYM
Bladder preservation with Panitumumab and radiotherapy.
- TRIAL ID
NTR3157
- ACRONYM
A randomized phase II study for evaluation of T cell depleted non myeloablative allogeneic stem cell transplantation followed by early consolidation with lenalidomide or lenalidomide combined with bortezomib and subsequent DLI for patients with multiple myeloma in progression or relapse following first line therapy.
- TRIAL ID
NTR2958
- ACRONYMHOVON 108 MM
A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma.
- TRIAL ID
NTR2528
- ACRONYMHOVON 95 MM
Gemcitabine en radiotherapie in combinatie met panitumumab bij patiënten met niet uitgezaaide, inoperabele alvleesklierkanker.
- TRIAL ID
NTR2441
- ACRONYMVectibix 20080686
Telenephrology Implementation.
- TRIAL ID
NTR2368
- ACRONYMCONTACT
The Dutch ITP-registry, a national web-based tool for collection of diagnostic, therapeutical and evaluation data from patients with chronic immune trombocytopenic purpura.
- TRIAL ID
NTR2308
- ACRONYMSTiC registry
A Phase II randomized multicenter study to assess the efficacy of lenalidomide with or without erythropoietin and granulocyte-colony stimulating factor in patients with low and intermediate-1 risk myelodysplastic syndrome.
- TRIAL ID
NTR1825
- ACRONYMHOVON 89 MDS
Bortezomib maintenance therapy in newly diagnosed patients with mantle cell lymphoma, responsive on rituximab combined with CHOP and high dose Ara-C and after BEAM with auto PSCT rescue.
- TRIAL ID
NTR1772
- ACRONYMHOVON 75 MCL
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II study
- TRIAL ID
NTR1461
- ACRONYMHOVON 88 CLL
Phase I/II trial of Lenalidomide plus Bortezomib combined with Dexamethasone in patients in 1st relapse or primary refractory after first line therapy for Multiple Myeloma.
- TRIAL ID
NTR1440
- ACRONYMHOVON 86 MM
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.
- TRIAL ID
NTR1380
- ACRONYMHOVON 85 NHL
Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab maintenance in elderly patients (66-80 years) with diffuse large B-cell lymphoma
- TRIAL ID
NTR1014
- ACRONYMHOVON 84 NHL
A randomized multicenter study of carboplatin-gemcitabine versus carboplatin-paclitaxel in elderly patients with non-small cell lung cancer with emphasis on geriatric assessment and quality of life:
The NVALT-3 study.
- TRIAL ID
NTR925
- ACRONYMChemotherapy in elderly patients
Imatinib in combination with Cytarabine as compared to Imatinib alone in patients with first chronic phase Chronic Myeloid Leukemia. A prospective randomized phase III study.
- TRIAL ID
NTR674
- ACRONYMHOVON 78 CML
Alemtuzumab as remission induction for adult patients with acute lymphoblastic leukemia in relapse; A randomized phase II study.
- TRIAL ID
NTR673
- ACRONYMHOVON 74 ALL
Randomized phase III study of Rituximab with intensified CHOP chemotherapy vs. Rituximab with High-Dose Sequential Therapy and Autologous Stem Cell Transplantation in Adult Patients (18-65 yrs) with Stage II-IV High-intermediate or High Risk DLBCL.
- TRIAL ID
NTR556
- ACRONYMHOVON 63 NHL
Three arm randomized parallel phase II/III study evaluating the efficacy and safety of the combinations Epirubicin and Taxotere (ET), Taxotere and Navelbine (TN) and Navelbine and Epirubicin (EN) as first line therapy in pat. with metastatic breast cancer.
- TRIAL ID
NTR472
- ACRONYMETN studie
Chemotherapy +/- vitamine supplementation in advanced Esophagogastric cancer.
- TRIAL ID
NTR470
- ACRONYMVitamine study
Value of Comprehensive Geriatric Assessment, clinical judgment, and performance status in the treatment of patients with epithelal ovarian carcinoma aged 70 years and older.
- TRIAL ID
NTR445
- ACRONYMCGA-trial
Autologous Stem cell Transplantation International Scleroderma ('ASTIS') Trial.
- TRIAL ID
NTR338
- ACRONYMASTIS-trial
Myelo-ablative chemo/radiotherapy and autologous stem cell transplantation as compared to only chemotherapy in patients with multiple myeloma.
- TRIAL ID
NTR321
- ACRONYMHOVON 24 MM
Effect of recombinant G-CSF on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin’s Lymphoma. A prospective phase III study.
- TRIAL ID
NTR320
- ACRONYMHOVON 25 NHL
Risk adapted treatment of acute myelocytic leukemia (AML).
- TRIAL ID
NTR291
- ACRONYMHOVON 29 AML/SAKK 30/95
High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemia.
- TRIAL ID
NTR290
- ACRONYMHOVON 38 CML
Microarray Analysis in breast cancer to Tailor Adjuvant Drugs Or Regimens, a randomized phase III study.
- TRIAL ID
NTR286
- ACRONYMMATADOR, BOOG 2005-02, CKTO 2004-04
Prevention of cardiovascular disease and progression of renal failure in patients with chronic renal insufficiency: implementation of maximal endothelial protection with the aid of nurse practitioners. A randomized multi-center study.
- TRIAL ID
NTR22
- ACRONYMMASTERPLAN (Multifactorial Approach and Superior Treatment Efficacy in